Isabel Kalofonos

Isabel Kalofonos

Corporate Officer/Principal bij CRINETICS PHARMACEUTICALS, INC.

Vermogen: 1 M $ op 31-05-2026

55 jaar
Health Technology
Consumer Services

Profiel

Isabel Kalofonos currently works at Crinetics Pharmaceuticals, Inc., as Chief Commercial Officer from 2024.
Ms. Kalofonos also formerly worked at Fulcrum Therapeutics, Inc., as Chief Commercial Officer in 2024, ImmunoGen, Inc., as Chief Commercial Officer & Senior Vice President from 2023 to 2024, and Galderma Holding SA, as Senior VP & Head-Prescription Business from 2020 to 2023.
Ms. Kalofonos received her Masters Business Admin degree from Babson College and undergraduate degree from Pontificia Universidad Javeriana.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
23-02-2026 34.834 ( 0,03% ) 1 M $ 31-05-2026

Actieve functies van Isabel Kalofonos

BedrijvenFunctieBegin
CRINETICS PHARMACEUTICALS, INC. Corporate Officer/Principal 16-12-2024

Eerdere bekende functies van Isabel Kalofonos

BedrijvenFunctieEinde
FULCRUM THERAPEUTICS, INC. Corporate Officer/Principal 30-09-2024
IMMUNOGEN, INC. Corporate Officer/Principal 01-08-2024
Corporate Officer/Principal 01-03-2023
Ervaring van Isabel Kalofonos in detail bekijken

Opleiding van Isabel Kalofonos

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

12

Eerstegraads connecties

6

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit6

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Isabel Kalofonos